Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-09-29
2011-12-06
Fetterolf, Brandon (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S724000
Reexamination Certificate
active
08071580
ABSTRACT:
Medium-chain length fatty alcohols such as octanol, decanol, dodecanol, or analogues thereof can be used as a stimulator of hematopoiesis, hematopoietic stem cell proliferation, and/or proliferation of one or more of the progenitors of red or white blood cells (e.g., erythrocyte, leukocyte, neutrophil, granulocyte, megakaryocyte, or any combination thereof). It also relates to the treatment of myelosuppression; in particular, this includes the treatment of anemia and/or neutropenia associated with chemotherapy and/or radiotherapy. Moreover, anemia arising from chronic renal failure or treatment of HIV-infected patients with AZT (zidovudine), or other inhibitors of reverse transcriptase, can be treated. Furthermore, neutropenia arising from infections, hematologic diseases, or nutritional deficiencies can be treated. It also relates to reducing drug toxicity and enhancing drug efficiency.
REFERENCES:
patent: 4812443 (1989-03-01), Takak et al.
patent: 4897426 (1990-01-01), Llinas et al.
patent: 4962129 (1990-10-01), Revici
patent: 2002/0028515 (2002-03-01), Talmadge et al.
patent: 2002/0076443 (2002-06-01), Stein et al.
patent: 2003/0072720 (2003-04-01), Nevo
patent: 2004/0147599 (2004-07-01), Gagnon et al.
patent: 2005/0020487 (2005-01-01), Klaus et al.
patent: 2006/0128800 (2006-06-01), Penney et al.
patent: 0 166 436 (1986-01-01), None
patent: 95/30413 (1995-11-01), None
patent: 02/083120 (2002-10-01), None
patent: 2004/069237 (2004-08-01), None
Macdougall, I. ‘Novel Erythropoiesis-Stimulating Agents: A New Era in Anemia Management’ Clincal Journal of the American Society of Nephrology, vol. 3, p. 200-207, 2008.
Hisha et al. “Isolation and Identification of Hematopoietic Stem Cell-Stimulating Substances from Kampo (Japanese Herbal) Medicine, Juzen-Taiho-To” Blood, 1997, vol. 90, No. 3, pp. 1022-1030.
Bug et al. “Valproic Acid Stimulates Proliferation and Self-Renewal of Hematopoietic Stem Cells” Cancer Research, 2005, vol. 65, No. 7, pp. 2537-2541.
Balleari et al., “In Vivo Effects of Thymustimulin on Hematopoiesis of Mice Treated with Cyclophosphamide,” Clin. Immunol. Immunopathol. 68:363-367, 1993 (abstract only).
Duffy et al., “Identification of a Pharmacophore for Thrombopoietic Activity of Small, Non-Peptidyl Molecules. 1. Discovery and Optimization of Salicylaldehyde Thiosemicarbazone Thrombopoietin Mimics,” J. Med. Chem. 45:3573-3575, 2002 (published on web Jul. 19, 2002).
Duffy et al., “Hydrazinonaphthalene and Azonaphthalene Thrombopoeitin Mimics are Nonpeptidyl Promoters of Megakaryocytopoiesis,” J. Med. Chem. 44:3730-3745, 2001 (published on web Sep. 13, 2001).
Ito et al., “Maitake Beta-Glucan Enhances Granulopoiesis and Mobilization of Granulocytes by Increasing G-CSF Production and Modulating CXCR4/SDF-1 Expression,” Int. Immunopharmacol. 9:1189-1196, 2009 (abstract only).
Kusano et al., “A Potential Therapeutic Role for Small Nonpeptidyl Compounds that Mimic Human Granulocyte Colony-Stimulating Factor,” Blood 103:836-842, 2004 (pre-published online Sep. 25, 2003).
Rodgers et al., “Effect of Angiotensin II and Angiotensin(1-7) on Hematopoietic Recovery after Intravenous Chemotherapy,” Cancer Chemother. Pharmacol. 51:97-106, 2003 (abstract only; Epub Dec. 19, 2002).
Wang et al., “Role of the Spleen in Cyclophosphamide-Induced Hematosuppression and Extramedullary Hematopoiesis in Mice,” Arch. Med. Res. 40:249-255, 2009 (abstract only; Epub Jun. 2, 2009).
International Search Report from International Application No. PCT/CA2005/001490, dated Nov. 1, 2005 (date of completion of search) and Dec. 7, 2005 (date of mailing of report).
Barabe Jean
Gagnon Lyne
Penney Christopher
Clark & Elbing LLP
Fetterolf Brandon
Prometic Biosciences Inc.
Stone Christopher R
LandOfFree
Medium-chain length fatty alcohols as stimulators of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medium-chain length fatty alcohols as stimulators of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medium-chain length fatty alcohols as stimulators of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4312176